Quiz

Article

Clinical Quiz: AGA Guideline for Fecal Microbiota-Based Therapies in Gastrointestinal Disease

Test your knowledge of the AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases with this clinical quiz!

On February 21, 2024, the American Gastroenterological Association (AGA) released the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal diseases. A guideline panel developed 7 recommendations intended to provide the basis for rational, informed decision-making for patients and healthcare professionals using fecal microbiota-based therapies for adults with recurrent Clostridioides difficile infection (CDI), severe to fulminant CDI, inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS).

In this clinical quiz, test your knowledge of the clinical recommendations for the use of fecal microbiota-based therapies in the 2024 American Gastroenterological Association Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.

What does the AGA suggest regarding fecal microbiota-based therapies in severely immunocompromised adults with recurrent CDI?



Reference:

  1. Peery AF, Kelly CR, Kao D, et al. American Gastroenterological Association Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases. Gastroenterology. https://www.gastrojournal.org/article/S0016-5085(24)00041-6/fulltext
Related Videos
Investigating Briquilimab’s Efficacy and Safety for CSU, with Thomas Casale, MD
What to Look Forward to at the American Academy of Dermatology Annual Meeting 2025
Ahmad Anouti, MD | Credit: UT Southwestern
Kent Lam I Credit: Macon & Joan Brock Virigina Health Sciences at Old Dominion University
Improving Care for ISM With Better Diagnosis, Disease Characterization, with Thanai Pongdee, MD
Skin of Color Savvy: Hair Loss Misconceptions, Clinical Insights, and Management, with Janiene Luke, MD, and Victoria Barbosa, MD, MPH
John Barbieri, MD, MBA | Credit: Brigham and Women's Hospital
© 2025 MJH Life Sciences

All rights reserved.